Elevation of vascular endothelial growth factor and distress in ovarian cancer patients: are they correlated? The pilot trial
https://doi.org/10.17650/1994-4098-2016-12-1-79-83
Abstract
In this pilot trial we analyzed the correlation between neoangiogenesis and psychological status in ovarian cancer patients. We found the correlation between depression levels and serum vascular endothelial growth factor levels in ovarian cancer patients – coefficient of rank correlation (ρ) was 0.42 (95 % confidence interval 0.01–0.72; р < 0,05), that suggests the relationship between this parameters.
About the Authors
G. P. Guens
Moscow State University of Medicine and Dentistry, Ministry of Health of Russia; 20/1 Delegatskaya St., Moscow, 127473, Russia
Russian Federation
Russian Federation
I. N. Oleynikova
Moscow State University of Medicine and Dentistry, Ministry of Health of Russia; 20/1 Delegatskaya St., Moscow, 127473, Russia
Russian Federation
Russian Federation
A. S. Kazanova
I.I. Mechnikov Scientific-Research Institute of Vaccines and Serums; 5a Malyy Kazennyy Per., Moscow, 105064, Russia
Russian Federation
Russian Federation
L. I. Korobkova
Moscow State University of Medicine and Dentistry, Ministry of Health of Russia; 20/1 Delegatskaya St., Moscow, 127473, Russia
Russian Federation
Russian Federation
I. I. Selezneva
N.A. Semashko Central Clinical Hospital No 2, JSC “Russian Railways”; 2 Budayskaya St., Moscow, 129128, Russia
Russian Federation
Russian Federation
V. V. Kirkin
Moscow State University of Medicine and Dentistry, Ministry of Health of Russia; 20/1 Delegatskaya St., Moscow, 127473, Russia
N.A. Semashko Central Clinical Hospital No 2, JSC “Russian Railways”; 2 Budayskaya St., Moscow, 129128, Russia
Russian Federation
Russian Federation
References
1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2012 г. М., 2014. 226 с. [Davydov М.I., Аksel’ Е.М. Statistics of malignant tumors in Russia and CIS countries in 2012. Мoscow, 2014. 226 p. (In Russ.)].
2. Holland J.C., Alici Y. Management of distress in cancer patients. J Support Oncol 2010;8(1):4–12.
3. Holland J., Watson M., Dunn J. The IPOS new International Standard of Quality Cancer Care: integrating the psychosocial domain into routine care. Psychooncology 2011;20(7):677–80.
4. Zabora J., BrintzenhofeSzoc K., Curbow B. et al. The prevalence of psychological distress by cancer site. Psychooncology 2001;10(1): 19–28.
5. Green McDonald P., O’Connell M., Lutgendorf S.K. Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations. Brain Behav Immun 2013;30 Suppl: S1–9.
6. Karamysheva A.F. Mechanisms of angiogenesis. Biochemistry (Mosc) 2008;73(7):751–62.
7. Yu L., Deng L., Li J. et al. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol 2013;128(2):391–6.
8. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Distress management. Version 2.2013. http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf (5 Мау 2014).
9. Graves K.D., Arnold S.M., Love C.L. et al. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 2007;55(2):215–24.
10. Tuinman M.A., Gazendam-Donofrio S.M., Hoekstra-Weebers J.E. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 2008;113(4):870–8.
11. Caccamo C., Nostro L., Giorgianni G. et al. Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. J Reprod Med 2007;52(11):1035–9.
12. Meraner V., Gamper E.M., Grahmann A. et al. Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer 2012;12:77.
13. Генс Г.П., Коробкова Л.И., Вельшер Л.З. и др. Взаимосвязь посттравматического стрессового расстройства и психоиммунных нарушений у больных раком молочной железы. В сб.: Психология: современные направления междисциплинарных исследований. Материалы конференции. Под ред. А. Журавлева и Н. Тарабриной. М.: Институт психологии РАН, 2003. С. 163–74. [Gens G.P., Korobkovа L.I., Vel’sher L.Z. et al. Interrelation of the post-traumatic stress disorder and psycho-immune diseases at patients with the mammary gland cancer. In: Psychology: modern trends of interdisciplinary studies. Conference materials. Ed. by А. Zhuravlev, N. Таrabrina. Мoscow: Institut psikhologii RAN, 2003. Pp. 163–74. (In Russ.)].
14. Mitchell A.J. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 2010;8(4):487–94.
15. Clark-Raymond A., Halaris A. VEGF and depression: a comprehensive assessment of clinical data. J Psychiatr Res 2013;47(8): 1080–7.
16. Elfving B., Buttenschøn H.N., Foldager L. et al. Depression and BMI influences the serum vascular endothelial growth factor level. Int J Neuropsychopharmacol 2014;17(9):1409–17.
17. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59(12):1116–27.
Review
For citations:
Guens G.P., Oleynikova I.N., Kazanova A.S., Korobkova L.I., Selezneva I.I., Kirkin V.V. Elevation of vascular endothelial growth factor and distress in ovarian cancer patients: are they correlated? The pilot trial. Tumors of female reproductive system. 2016;12(1):79-83. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-1-79-83
Views:
716
Email this article 